- Filed
- Nov 14, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 13, 2024 | 512.55M sh |
| Long Term Debt | Q3 2024 · Sep 30, 2024 | $25.29M |
| Long Term Debt | Q3 2024 · Dec 31, 2023 | $22.69M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $35.76M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $70.17M |
| Stockholders Equity | Q3 2024 · Sep 30, 2024 | $319.57M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $325.31M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $48.84M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $56.99M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $110.7M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $115.04M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $211.81M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $226.45M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $470.11M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $478.35M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 56.29M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 56.96M sh |
| Stock Repurchased | Q3 2024 · Sep 30, 2023 | $18.59M |
| Capex | Q3 2024 · Sep 30, 2023 | $5.66M |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$30.72M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.17 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.02 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.17 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.02 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $6.96M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $16.69M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$9.39M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$1.24M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$3.96M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$1.92M |
| Gross Profit | Q3 2024 · Sep 30, 2023 | $5.69M |
| Gross Profit | Q3 2024 · Sep 30, 2023 | $19.94M |
| Cost Of Revenue | Q3 2024 · Sep 30, 2023 | $8.26M |
| Cost Of Revenue | Q3 2024 · Sep 30, 2023 | $40.73M |